Keyphrases
Head-and-neck Cancer
100%
Gene Therapy
100%
Interleukin Genes
100%
Mode of Delivery
28%
Clinical Trials
14%
Gene Expression
14%
Interleukin-12 (IL-12)
14%
Advanced Stage
14%
Therapeutic Efficacy
14%
Expert Opinion
14%
Innovative Therapies
14%
Future Therapeutics
14%
Cancer Treatment
14%
Adverse Effects
14%
Tumor Microenvironment
14%
Chemotherapy
14%
Oral Cavity
14%
Interleukin-2
14%
Current Therapies
14%
High Morbidity
14%
Tumor-related Genes
14%
Oropharynx
14%
Targeted Tumor
14%
Squamous Epithelium
14%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
14%
Gene Delivery System
14%
Therapy Techniques
14%
Area Cover
14%
IL-24
14%
Combined Treatment
14%
Medicine and Dentistry
Cytokine
100%
Head and Neck Cancer
100%
Gene Therapy
100%
Combination Therapy
14%
Clinical Trial
14%
Gene Expression
14%
Larynx
14%
Cancer Therapy
14%
Tumor Microenvironment
14%
Oral Cavity
14%
Experimental Therapy
14%
Interleukin 12
14%
Gene Targeting
14%
Specific Tumor
14%
Oropharynx
14%
Squamous Epithelium
14%
Head and Neck Squamous Cell Carcinoma
14%
Immunosuppressive Drug
14%
Interleukin 2
14%
Immunotherapy
14%
Interleukin 24
14%
Adverse Effect
14%
Pharmacology, Toxicology and Pharmaceutical Science
Cytokine
100%
Head and Neck Cancer
100%
Preclinical Study
16%
Clinical Trial
16%
Chemotherapy
16%
Immunosuppressive Agent
16%
Interleukin 12
16%
Neoplasm
16%
Gene Delivery
16%
Interleukin 2
16%
Combination Therapy
16%
Immunotherapy
16%
Tumor Microenvironment
16%
Head and Neck Squamous Cell Carcinoma
16%
Interleukin 24
16%